Artwork

Contenu fourni par Mary Ann Liebert, Inc. and Mary Ann Liebert. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mary Ann Liebert, Inc. and Mary Ann Liebert ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Episode #6: The Importance of Fever Prevention in Clinical Practice

38:23
 
Partager
 

Manage episode 340465123 series 3381948
Contenu fourni par Mary Ann Liebert, Inc. and Mary Ann Liebert. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mary Ann Liebert, Inc. and Mary Ann Liebert ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
The podcast entitled “The Importance of Fever Prevention in Clinical Practice” with Dr. Shahed Toossi, Assistant Professor of Neurology and Neurological Surgery, Cedars Sinai Medical Center and Dr. Rainer Lenhardt, Professor and Vice Chair for Clinical Affairs, Department of Anesthesiology and Perioperative Medicine, University of Louisville covered several important topics. The occurrence of fever in clinical practice and mechanisms underlying postinjury temperature elevations were discussed. Also, whether or not the clinical literature had convincingly demonstrated whether preventing fever actually improved clinical outcomes was also debated. Issues regarding specific patient populations where prophylactic fever avoidance might be most effective and the significance of the recent TTM2 trial for cardiac arrest where targeted normothermia (37.8oC) was directly compared to targeted hypothermia (33oC) was mentioned. There are multiple strategies for preventing and treating periods of fever and the advantages of these approaches were discussed. The issue of patient heterogeneity in clinical trials was emphasized and the goals of the ICECAP trial where optimal durations of hypothermia treatment are being evaluated was discussed. This rich discussion generated several unanswered questions again emphasizing the continued interest in this experimental treatment strategy and the need for additional research.
  continue reading

108 episodes

Artwork
iconPartager
 
Manage episode 340465123 series 3381948
Contenu fourni par Mary Ann Liebert, Inc. and Mary Ann Liebert. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mary Ann Liebert, Inc. and Mary Ann Liebert ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
The podcast entitled “The Importance of Fever Prevention in Clinical Practice” with Dr. Shahed Toossi, Assistant Professor of Neurology and Neurological Surgery, Cedars Sinai Medical Center and Dr. Rainer Lenhardt, Professor and Vice Chair for Clinical Affairs, Department of Anesthesiology and Perioperative Medicine, University of Louisville covered several important topics. The occurrence of fever in clinical practice and mechanisms underlying postinjury temperature elevations were discussed. Also, whether or not the clinical literature had convincingly demonstrated whether preventing fever actually improved clinical outcomes was also debated. Issues regarding specific patient populations where prophylactic fever avoidance might be most effective and the significance of the recent TTM2 trial for cardiac arrest where targeted normothermia (37.8oC) was directly compared to targeted hypothermia (33oC) was mentioned. There are multiple strategies for preventing and treating periods of fever and the advantages of these approaches were discussed. The issue of patient heterogeneity in clinical trials was emphasized and the goals of the ICECAP trial where optimal durations of hypothermia treatment are being evaluated was discussed. This rich discussion generated several unanswered questions again emphasizing the continued interest in this experimental treatment strategy and the need for additional research.
  continue reading

108 episodes

Tous les épisodes

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide